The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
One of the most ambitious programs to roll out oral PrEP to populations at risk of HIV so far is Jilinde, and run by Jhpiego (a Johns Hopkins University affiliate). Jilinde has built in a robust evaluation process that continuously tests and changes its messages and outreach aimed at adolescent girls and young women (AGYW), among other populations.
As we approach 2020, we see enormous possibilities to advance toward our collective goal to end the HIV epidemic–and we see even more enormous opportunities for our work together!
What’s all the fuss about F/TAF? Listen to this new episode of our Px Pulse podcast for a snapshot of the issue and a preview of what will take much of AVAC’s – and our partners’ – attention in 2020.
As part of an analysis funded by the OPTIONS Consortium (of which AVAC is a part), AVAC examined historical experiences introducing products that share characteristics with the dapivirine vaginal ring, specifically, products that were vaginally inserted and/or partially efficacious.
AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.